Survey of patients with acute coronary syndromes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect data on patients presenting with acute coronary syndromes, including unstable angina and myocardial infarction, across various centers in Eastern Europe. It will document patient characteristics, in-hospital outcomes, and treatment regimens to assess adherence to established guidelines. The study will also evaluate the complications associated with invasive procedures and track patient outcomes at six months and one year post-treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* acute coronary syndromes

Exclusion Criteria:

* under age or not able to give informed consent

Where it's running

• University of Bologna
  Bologna, Emilia-Romagna, Italy Recruiting

Study contacts

• Principal investigator: Raffaele Bugiardini, MD — University of Bologna
• Study coordinator: Raffaele Bugiardini, MD
• Email: raffaele.bugiardini@unibo.it
• Phone: +39 335 5612962

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Freesolve resorbable magnesium scaffold vs. Xience stent for up to two new heart artery lesions

  This trial tests whether the Freesolve resorbable magnesium scaffold works as well as the Xience drug-eluting stent for treating up to two new coronary artery lesions in adults.

  Recruiting at 3 sites Teleflex · Washington D.C., District of Columbia and 2 other locations · NCT07258290

• Healthy Nordic diet's effects on heart disease

  This study is testing if following a Healthy Nordic diet can help people with coronary heart disease improve their heart health over 18 months.

  Recruiting Uppsala University · Uppsala · NCT06701968

• Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients

  This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.

  Recruiting Fondazione Ricerca e Innovazione Cardiovascolare ETS · Milan, MI · NCT06535568

• Understanding sex hormones and inflammation in heart disease

  This study looks at how sex hormones and inflammation affect heart disease in women to better understand their unique risks and improve treatment.

  Recruiting Queen Mary University of London · London · NCT06327984

• Effects of Dapagliflozin on Heart Health in Patients with Acute Coronary Syndromes

  This study is testing if dapagliflozin, a diabetes medication, can improve heart health in people who have just had a heart attack.

  Recruiting Phase 2/3 University of Sao Paulo · São Paulo, São Paulo · NCT06286878

• Using magnetocardiography to identify heart attacks

  This study is testing if a new noninvasive heart scan method can help doctors better identify heart attacks in people with chest pain and healthy volunteers.

  Recruiting Qilu Hospital of Shandong University · Jinan, Shandong · NCT05896826

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.